EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival

T Jeethy Ram, Asha Lekshmi, Pramod Darvin, Prakash Rajappan, K M Jagathnath Krishna, T M Anoop, Paul Augustine, Arun Peter Mathew, Kurian Cherian, Rexeena V Bhargavan, Thara Somanathan, M Radhakrishna Pillai und 2 weitere

Tumor Biology · 10.08.2023 · 45 (1) · 31-54

DOI: 10.3233/tub-230002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 10.08.2023. Verfasst von T Jeethy Ram und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Research, Regional Cancer Centre, Thiruvananthapuram, Kerala, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lack of druggable targets and complex expression heterogeneity of known targets is common among TNBC subtypes. An enhanced expression of galectin-3 in TNBCs has already been documented. We have observed a tumor progression-dependent galectin-3 expression in TNBCs compared to adjacent epithelium and non TNBCs. OBJECTIVE: To unravel the association of galectin- 3 in tumor progression, aggressiveness and drug resistance in TNBC patients. METHODS: Galectin-3 expression in 489 breast cancer tissues was correlated with clinicopathological features and the results were validated in cell lines and mouse model by silencing galectin-3 using shRNA and the proteins were profiled by western blot and qRT-PCR. Protein interaction was analyzed by GFP Trap and Mass spectrometry. RESULTS: Galectin-3 expression correlated with tumor stage in TNBC and a lower galectin-3 expression was associated with poor patient survival. The positive correlation between galectin-3, vimentin and CD44 expression, pinpoints galectin-3 contribution to epithelial to mesenchymal transition, drug resistance and stemness. Vimentin was found as an interacting partner of galectin-3. Duplexing of galecin-3 and vimentin in patient samples revealed the presence of tumor cells co-expressing both galectin-3 and vimentin. In vitro studies also showed its role in tumor cell survival and metastatic potential, elementary for tumor progression. In vivo studies further confirmed its metastatic potential. CONCLUSIONS: Tumor progression dependent expression pattern of galectin 3 was found to indicate prognosis. Co-expression of galectin-3 and vimentin in tumor cells promotes tumor dissemination, survival and its metastatic capability in TNBCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAnimalsHumansMiceCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionGalectin 3Gene Expression Regulation, NeoplasticVimentin

Stichwörter der Autor:innen

Epithelial mesenchymal transitionchemoresistancegalectin-3metastasistumor survivalvimentin

Substanzen

Galectin 3Vimentin

Autor:innen und Institutionen

  • Division of Cancer Research, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
  • Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.
  • Epidemiology & Biostatistics, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
  • Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
  • Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Zitieren

APA

Jeethy Ram, T., Lekshmi, A., Darvin, P., Rajappan, P., Jagathnath Krishna, K. M., Anoop, T. M., Augustine, P., Mathew, A. P., Cherian, K., Bhargavan, R. V., Somanathan, T., Radhakrishna Pillai, M., Santhosh Kumar, T. R., & Sujathan, K. (2023). Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival. Tumor Biology, 45(1), 31-54. https://doi.org/10.3233/tub-230002

Vancouver

Jeethy Ram T, Lekshmi A, Darvin P, Rajappan P, Jagathnath Krishna KM, Anoop TM, et al. Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival. Tumor Biology. 2023;45(1):31-54. doi:10.3233/tub-230002

BibTeX
@article{JeethyRam2023,
  author = {Jeethy Ram, T and Lekshmi, Asha and Darvin, Pramod and Rajappan, Prakash and Jagathnath Krishna, K M and Anoop, T M and Augustine, Paul and Mathew, Arun Peter and Cherian, Kurian and Bhargavan, Rexeena V and Somanathan, Thara and Radhakrishna Pillai, M and Santhosh Kumar, T R and Sujathan, K},
  title = {Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival},
  journal = {Tumor Biology},
  year = {2023},
  volume = {45},
  number = {1},
  pages = {31--54},
  doi = {10.3233/tub-230002}
}
Kostenlos starten →